Mettler-Toledo Total Long Term Liabilities 2010-2025 | MTD

Mettler-Toledo total long term liabilities for the quarter ending March 31, 2025 were $2.267B, a 1.86% decline year-over-year.

  • Mettler-Toledo total long term liabilities for 2024 were $2.199B, a 5.41% decline from 2023.
  • Mettler-Toledo total long term liabilities for 2023 were $2.324B, a 0.2% increase from 2022.
  • Mettler-Toledo total long term liabilities for 2022 were $2.32B, a 15.48% increase from 2021.

Mettler-Toledo Total Long Term Liabilities 2010-2025 | MTD

  • Mettler-Toledo total long term liabilities for 2024 were $2.199B, a 5.41% decline from 2023.
  • Mettler-Toledo total long term liabilities for 2023 were $2.324B, a 0.2% increase from 2022.
  • Mettler-Toledo total long term liabilities for 2022 were $2.32B, a 15.48% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$180.2B
Intuitive Surgical (ISRG)$179.4B
Edwards Lifesciences (EW)$47.6B
IDEXX Laboratories (IDXX)$46B
Alcon (ALC)$44B
DexCom (DXCM)$34.9B
IQVIA Holdings (IQV)$32.6B
STERIS (STE)$22.6B
Waters (WAT)$17.8B
SONOVA HOLDING (SONVY)$16.4B
Hologic (HOLX)$14.5B
Sysmex ADR (SSMXY)$10.4B
Penumbra (PEN)$9.8B
Masimo (MASI)$8.5B
Globus Medical (GMED)$7.2B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.6B
PROCEPT BioRobotics (PRCT)$2.8B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.9B
Veracyte (VCYT)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Tandem Diabetes Care (TNDM)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$991M